FTRE
Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.42
−0.31%Forward multiples
Based on analyst estimates
- P/E forward
- 22.06x
- P/E 2026E
- 27.18x
- P/E 2027E
- 21.68x
- P/E 2028E
- 17.10x
- P/S forward
- 0.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.07x
- Price / sales
- 0.80x
- Price / cash flow
- 11.69x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 1.15x
- EV / EBITDA
- 37.94x
- EV / EBIT
- 280.09x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026